Delta variant neutralizing antibody response following maternal COVID-19 vaccination
- 7 September 2023
- journal article
- research article
- Published by Elsevier in American Journal of Infection Control
- Vol. 52 (2) , 252-254
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- COVID-19 Cases and Disease Severity in Pregnancy and Neonatal Positivity Associated With Delta (B.1.617.2) and Omicron (B.1.1.529) Variant PredominanceJAMA, 2022
- Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural InfectionJAMA, 2022
- Maternal and Perinatal Outcomes Associated With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta (B.1.617.2) VariantObstetrics & Gynecology, 2021
- Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant WomenJAMA, 2021
- Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020MMWR. Morbidity and Mortality Weekly Report, 2020